Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups

Published:2016-07-07 Issue:1 Volume:18 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Netanely Dvir,Avraham Ayelet,Ben-Baruch Adit,Evron Ella,Shamir Ron

Funder

Israeli Science Foundation

Dotan Center in Hemato-Oncology

Israeli Center of Research Excellence (I-CORE), Gene Regulation in Complex Human Disease

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-016-0724-2.pdf

Reference73 articles.

1. Bertos NR, Park M. Review series breast cancer – one term, many entities? J Clin Invest. 2011;121:3789–96.

2. Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thürlimann B, Senn H-J. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol. 2009;20:1319–29.

3. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci. 1998;95:14863–8.

4. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747–52.

5. Reis-Filho JS, Pusztai L. Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet. 2011;378:1812–23.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of the BTLA–HVEM complex in the pathogenesis of breast cancer;Breast Cancer;2024-03-14

2. Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer;Proceedings of the National Academy of Sciences;2024-02-06

3. Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16);European Journal of Cancer;2023-12

4. An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers;Cancer Research Communications;2023-09-29

5. Precise subtyping reveals immune heterogeneity for hormone receptor-positive breast cancer;Computers in Biology and Medicine;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3